Pharmaceutically active compounds
    2.
    发明授权
    Pharmaceutically active compounds 失效
    药物活性化合物

    公开(公告)号:US06794387B2

    公开(公告)日:2004-09-21

    申请号:US10099264

    申请日:2002-03-14

    IPC分类号: C07D48704

    CPC分类号: C07D487/04

    摘要: Compounds of general formula (I): wherein R1, R2, R3, R4, X, Y and A have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.

    摘要翻译: 通式(I)的化合物:其中R 1,R 2,R 3,R 4,X,Y和A具有本文给出的用于治疗和预防性治疗 需要抑制环鸟苷3',5'-单磷酸磷酸二酯酶(如cGMP PDE5)的医疗条件。

    PYRAZINE DERIVATIVES
    4.
    发明申请
    PYRAZINE DERIVATIVES 审中-公开
    吡嗪衍生物

    公开(公告)号:US20100227872A1

    公开(公告)日:2010-09-09

    申请号:US12598308

    申请日:2008-04-21

    申请人: Mark Ian Kemp

    发明人: Mark Ian Kemp

    CPC分类号: C07D413/12 C07D403/12

    摘要: The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.

    摘要翻译: 本发明涉及下式的化合物及其药学上可接受的盐和溶剂化物,其制备方法,用于制备的中间体和含有这些化合物的组合物以及这些化合物用于治疗疼痛的用途。

    Pharmaceutically active compounds
    9.
    发明授权
    Pharmaceutically active compounds 失效
    药物活性化合物

    公开(公告)号:US06784185B2

    公开(公告)日:2004-08-31

    申请号:US10098900

    申请日:2002-03-14

    IPC分类号: C07D48704

    CPC分类号: C07D487/04

    摘要: Compounds of general formula I: or pharmaceutically or veterinarily acceptable salts, solvates, polymorphs or pro-drugs thereof wherein: wherein R1, R2, R3, R4, X and A have the meanings given herein which are useful in the curative and prophylactic treatment of a medical condition for which inhibition of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase (e.g. cGMP PDE5) is desired.

    摘要翻译: 通式I的化合物:或其药学或兽医学上可接受的盐,溶剂化物,多晶型物或其前体药物,其中:其中R 1,R 2,R 3,R 4,X和A具有 可用于治疗性和预防性治疗期望抑制环鸟嘌呤3',5'-单磷酸磷酸二酯酶(例如cGMP PDE5)的医学病症。